Back
Editas Medicine Vs. Regencell Bioscience Holdings Industry Stock Comparison
Sell
3
EDIT
Editas Medicine
Last Price:
$1.29
Seasonality Move:
-5.52%
Sell
47
RGC
Regencell Bioscience Holdings
Last Price:
$42.91
Seasonality Move:
5.37%
Sell
3
Editas Medicine (EDIT)
is a Sell
Is Editas Medicine a Buy, Sell or Hold?
-
The current Editas Medicine [EDIT] share price is $1.30. The Score for EDIT is 3, which is 94% below its historic median score of 50, and infers higher risk than normal.
-
EDIT is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
47
Regencell Bioscience Holdings (RGC)
is a Sell
Is Regencell Bioscience Holdings a Buy, Sell or Hold?
-
The current Regencell Bioscience Holdings [RGC] share price is $42.50. The Score for RGC is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
RGC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EDIT Stock Price Chart
What is Editas Medicine's stock price today?
-
The Editas Medicine share price today is $1.30Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EDIT is experiencing selling pressure, which indicates risk of future bearish movement.
RGC Stock Price Chart
What is Regencell Bioscience Holdings's stock price today?
-
The Regencell Bioscience Holdings share price today is $42.50Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RGC is experiencing slight buying pressure.
EDIT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.3 | Buy |
Relative Strength Index (14 RSI): | 42.85 | Sell |
Chaikin Money Flow: | -876975 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.29 - 2.07) | Sell |
Bollinger Bands (100): | (1.18 - 2.5) | Sell |
RGC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 10.52 | Buy |
Relative Strength Index (14 RSI): | 70.23 | Buy |
Chaikin Money Flow: | 210161 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (-1.72 - 30.8) | Buy |
Bollinger Bands (100): | (-1.47 - 16.73) | Buy |
EDIT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.37 | Sell |
20-day SMA: | 1.59 | Sell |
50-day SMA: | 1.48 | Sell |
200-day SMA: | 3.09 | Sell |
8-day EMA: | 0.85 | Buy |
20-day EMA: | 0.44 | Buy |
50-day EMA: | 0.2 | Buy |
200-day EMA: | 0.05 | Buy |
RGC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 35.08 | Buy |
20-day SMA: | 17.13 | Buy |
50-day SMA: | 9.4 | Buy |
200-day SMA: | 6.9 | Buy |
8-day EMA: | 35.87 | Buy |
20-day EMA: | 23 | Buy |
50-day EMA: | 13.41 | Buy |
200-day EMA: | 8.3 | Buy |
Editas Medicine Earnings Growth & EDIT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.02 per share, an increase this year of $1.12 per share, and an increase next year of $0.41 per share.
Regencell Bioscience Holdings Earnings Growth & RGC Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Editas Medicine Technical Analysis
Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Regencell Bioscience Holdings Technical Analysis
Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |